Skip to content
TrialScanner

NCT03905330

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Phase 3CompletedMIRMLead

Registry record

Lead sponsor
Mirum Pharmaceuticals, Inc.
Conditions
Progressive Familial Intrahepatic Cholestasis (PFIC)
Primary completion
Sep 1, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03905330 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03905330: A Study to Evaluate the... | TrialScanner